Stock screener

BVS

Conviction 67HealthcareScan · Thu, Jun 25, 2026
BVS$9.73+2.42%
ResistanceSupportVol 14
63 bars
Vol MA14 603.7K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Bioventus Inc.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.bioventus.com
Price9.73
Change+2.42%
Gap-1.32%
Rel volume1.79×
Avg volume693.24K
Avg $ vol6.08M
SMA 208.80
SMA 509.61
SMA 2008.23
Price vs 50+1.28%
Price vs 200+18.23%
MA stackbullish
50/200 cross
Supertrendup · 8.30
RSI (14)60
MACD hist0.15
MACD crossbull · 6d
Stoch %K / %D97 / 91
ADX (14)18
+DI / −DI27 / 20
RSI divergence
MACD divergence
ATR %+4.52%
ADR %4.46%
52w high10.94
52w low6.14
From 52w high-11.06%
Above 52w low+58.47%
New 52w highNo
SqueezeOff
Bollinger width19.05%
%B1.06
Donchian pos98.21%
Donchian high9.77
Donchian low7.81
AVWAP (52w high)9.27
vs AVWAP high+4.92%
AVWAP (52w low)8.35
vs AVWAP low+16.54%
OBV trendUp
Chaikin MF (20)0.02
Today vs 20d1.79×
Avg vol (14d)603.7K
Avg vol (20d)693.24K
Avg $ vol (20d)6.08M
Market cap670.54M
RS 3m (vs SPY)-8.43%
RS 6m (vs SPY)+19.10%
RS line new highNo
Trend template7/8
Technical rank81.9
1 week+13.93%
1 month+7.87%
3 months+6.22%
6 months+30.08%
1 year+43.93%
YTD+34.95%
P/E29.50
P/B3.55
P/S1.18
P/FCF9.30
EPS0.3300
Div yield
ROE12.03%
ROA3.49%
Debt/Eq1.44
Current1.69
EV/EBITDA8.98
Gross margin68.33%
Net margin4.00%
Rev growth-0.91%
EPS growth162.93%
Price target14.33
Target upside47.28%
Analyst ratingBuy
Institutional81.53%
Ent. value906.77M
Revenue132.09M
Net income3.11M
Gross profit90.77M
Free cash flow72.11M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out67.75M
Employees940
ListedThu, Feb 11, 2021
Free float38.83M
Float %58.0%
Short interest1.84M
Days to cover2.5d
Short volume73.0%
Squeeze score54 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast$0.21 · 2 est
Last EPS vs est$0.15 vs $0.09
Last surprise+66.7% beat
Setup gradeB
Conviction67 / 100
Pattern quality
Tech rank81.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance11.12
Support8.10
Days since event
Candle confirm
News sentiment

Financials as of Sat, Mar 28, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BVS

All disclosures →
No recent disclosed trades by Congress in BVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BVS · 10 buys

InsiderSideShares
STALNECKER SUSAN M
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
McMurry-Heath Michelle
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
SUTTER MARTIN P
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
Bartholdson John A.
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
Cowdy Philip G.
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
Ladone Mary Kay
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
HAWKINS WILLIAM A
Director · Restricted Stock Units · 2026-06-03
Grant30.99K
NOHRA GUY P
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
Beyer Pat
Director · Restricted Stock Units · 2026-06-03
Grant25.15K
NEELS GUIDO J
Director · Restricted Stock Units · 2026-06-03
Grant25.15K

SEC filings

EDGAR filings in BVS · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.